Cysal

New Materials

Cysal GmbH produces arginyl-aspartate and lysyl-aspartate (dipeptides) on an industrial scale by means of an internationally patented biotechnological process. The biotechnological company uses these dipeptides, i.e. the bond of two amino acids, as a basis for the production of specially developed end products such as energy tonics, skin creams, animal feed or infusion agents. In addition Cysal licences its technology to relevant industrial corporates.

Headquarter
M√ľnster, Germany
Status
active